Effect of Blueberries on Immunity and Response to Flu Vaccination
NCT ID: NCT05534893
Last Updated: 2025-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
52 participants
INTERVENTIONAL
2022-10-12
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity
NCT01896154
Snack Foods and Their Impact on the Immune Response Following Influenza Vaccination
NCT05515263
Cranberry Supplementation, Viral Defense, Antibody Response to the Flu Shot
NCT04597554
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
NCT04101838
Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok
NCT00539981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blueberry powder group
Participants in the blueberry powder group will receive freeze dried blueberries in form of a powder
Blueberry powder group
Participants in the blueberry powder group will receive freeze dried blueberries in form of a powder
Placebo powder group
Participants in the placebo powder group will receive an isocaloric placebo powder
Placebo powder group
Participants in the placebo group will receive an isocaloric placebo powder.
Blueberry powder group
Participants in the blueberry powder group will receive freeze dried blueberries in form of a powder
Placebo powder group
Participants in the placebo powder group will receive an isocaloric placebo powder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blueberry powder group
Participants in the blueberry powder group will receive freeze dried blueberries in form of a powder
Placebo powder group
Participants in the placebo powder group will receive an isocaloric placebo powder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Regular intake of Blueberries and other berried (\>2 ounces/week)
3. Immune system insufficiency or disease
4. Using immune boosting supplements
5. Exposure to antibiotics and corticoids immediately prior to study
6. Uncontrolled chronic diseases and relevant psychiatric illness, including major depression
7. Flu vaccination less than 10 months ago from the start of the study
50 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
U.S. Highbush Blueberry Council
OTHER
Loma Linda University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joan Sabate, DrPH
Role: PRINCIPAL_INVESTIGATOR
Loma Linda University
Sujatha Rajaram, PhD
Role: PRINCIPAL_INVESTIGATOR
Loma Linda University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University School of Public Health
Loma Linda, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5220098
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.